Procept Overview

  • Year Founded
  • 1985

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Procept General Information

Description

Developer of therapeutic drugs to manage diseases of the immune system. The company focuses on drug product development for AIDS, autoimmune disease, organ transplant rejection and allergies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 840 Memorial Drive
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 840 Memorial Drive
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Procept Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 28-Jan-2000 Completed Generating Revenue
2. IPO 17-Feb-1994 Completed Generating Revenue
1. Early Stage VC 22-Aug-1990 $9.2M $9.2M Completed Product Development
To view Procept’s complete valuation and funding history, request access »

Procept Patents

Procept Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2108099-A Immunosuppressive agents Inactive 30-Jan-1998
WO-1999038846-A1 Immunosuppressive agents Inactive 30-Jan-1998
ES-2224385-T3 Composition of condensation polymer to prevent pregnancy. Inactive 01-May-1997
AU-7260198-A Condensation polymer composition for preventing pregnancy Active 01-May-1997
AU-732693-B2 Condensation polymer composition for preventing pregnancy Inactive 01-May-1997 A61K31/795
To view Procept’s complete patent history, request access »

Procept Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bristol-Myers Squibb Corporation Minority
HealthCare Ventures Venture Capital Minority
Montgomery Medical Ventures Venture Capital Minority
Rho Acceleration Venture Capital Minority
To view Procept’s complete investors history, request access »

Procept Acquisitions (1)

Procept’s most recent deal was a Reverse Merger with HeavenlyDoor.com. The deal was made on 28-Jan-2000.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
HeavenlyDoor.com 28-Jan-2000 Reverse Merger Other Services (B2C Non-Financial)
To view Procept’s complete acquisitions history, request access »

Procept FAQs

  • When was Procept founded?

    Procept was founded in 1985.

  • Where is Procept headquartered?

    Procept is headquartered in Cambridge, MA.

  • What industry is Procept in?

    Procept’s primary industry is Drug Discovery.

  • Is Procept a private or public company?

    Procept is a Private company.

  • What is Procept’s current revenue?

    The current revenue for Procept is .

  • How much funding has Procept raised over time?

    Procept has raised $28.1M.

  • Who are Procept’s investors?

    Bristol-Myers Squibb, HealthCare Ventures, Montgomery Medical Ventures, and Rho Acceleration have invested in Procept.

  • When was Procept acquired?

    Procept was acquired on 28-Jan-2000.

  • Who acquired Procept?

    Procept was acquired by HeavenlyDoor.com.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process